The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

Journal of Clinical Investigation

Volumn 109, Issue 7, 2002, Pages 883-893

  Kabashima, Kenji ^a   Saji, Tomomi ^a   Murata, Takahiko ^a   Nagamachi, Miyako ^a   Matsuoka, Toshiyuki ^a   Segi, Eri ^a   Tsuboi, Kazuhito ^a   Sugimoto, Yukihiko ^a   Kobayashi, Takuya ^a   Miyachi, Yoshiki ^a   Ichikawa, Atsushi ^a   Narumiya, Shuh ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 CYANO 2 [2 (4 FLUORONAPHTHALEN 1 YL)PROPIONYLAMINO]PHENYL]BUTYRIC ACID; 7 [3 HYDROXY 2 [3 HYDROXY 4 (3 METHOXYMETHYLPHENYL) 1 BUTENYL] 5 OXOCYCLOPENTYL] 5 THIAHEPTANOIC ACID METHYL ESTER; AE 1734; AE 3208; BUTYRIC ACID DERIVATIVE; CD4 ANTIGEN; DEXTRAN; INDOMETACIN; PROSTAGLANDIN D; PROSTAGLANDIN D RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E1 RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E3 RECEPTOR; PROSTAGLANDIN E4 RECEPTOR; PROSTAGLANDIN E4 RECEPTOR ANTAGONIST; PROSTAGLANDIN F; PROSTAGLANDIN F RECEPTOR; PROSTAGLANDIN RECEPTOR; PROSTANOID RECEPTOR; SODIUM SULFATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DISEASE SEVERITY; DNA MICROARRAY; EPITHELIUM; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOREGULATION; INTESTINE CELL; INTESTINE MUCOSA; LAMINA PROPRIA; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN DEFECT; PROTEIN STRUCTURE; TH1 CELL; WILD TYPE;

EID: 0036221333     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214459     Document Type: Article

References (44)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease
3. Inflammatory bowel disease incidence: Up, down or unchanged?
4. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
5. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease
6. Effects ofnonsteroidal anti-inflammatory drugs on inflammatory bowel disease: A case-control study
7. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
8. Eicosanoids and the large intestine
9. Prostanoid receptors: Structures, properties, and functions
10. Role of Prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine
11. Effects of ulcerative colitis activity on plasma and mucosal prostaglandin E2 concentration
12. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper
13. Experimental models of inflammatory bowel disease
14. Impaired febrile response in mice lacking the prostaglandin E receptor subtype 3
15. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2
16. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice
17. 2 as a mediator of allergic asthma
18. Failure of parturition in mice lacking the prostaglandin F receptor
19. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
20. Characterization of prostanoid receptors mediating contraction of the gastric fundus and lieum: Studies using mice deficient in prostanoid receptors
21. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
22. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic
23. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1
24. Clinicopathologic study of dextran sulfate sodium experimental murine colitis
25. Intestinal transmission of macromolecules (BSA and FITC-labelled dextrans) in the neonatal pig. Influence of age of piglet and molecular weight of markers
26. Systemically derived large intestinal CD4+ Th2 cells play a central role in STAT6-mediated allergic diarrhea
27. Prostanoids in human colonic mucosa: Effects of inflammation on PGE2 receptor expression
28. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats
29. Treatment with 16,16'-deimethyl PGE2 before and after induction of colitis with trinitrobenzene sulfonic acid in rats decreases inflammation
30. Prostaglandins prevent decreased the epithelial proliferation associated with dextran sodium sulfate injury in mice
31. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease
32. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen
33. Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin E2 production by stromal cells in the murine small intestine lamina propria: Directing the tone of the intestinal immune response
34. Exacerbation of inflammation-associated colonic injury in rat through inhibition ofcyclooxygenase-2
35. COX-2: Promoting tolerance
36. Regulation of TNF alpha and interleukin-10 production by prostaglandins I(2) and E(2): Studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists
37. Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils
38. The biology of chemokines and their receptors
39. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4(+)-cell depleted, athymic and NK cell depleted SCID mice
40. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
41. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Thl and Th2 cytokines
42. A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacrerial antigens
43. + T cells
44. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) Thl-like responses